43 related articles for article (PubMed ID: 1309218)
1. Manganese-Enhanced Magnetic Resonance Imaging: Overview and Central Nervous System Applications With a Focus on Neurodegeneration.
Cloyd RA; Koren SA; Abisambra JF
Front Aging Neurosci; 2018; 10():403. PubMed ID: 30618710
[TBL] [Abstract][Full Text] [Related]
2. Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation.
Wang J; Wang H; Ramsay IA; Erstad DJ; Fuchs BC; Tanabe KK; Caravan P; Gale EM
J Med Chem; 2018 Oct; 61(19):8811-8824. PubMed ID: 30204438
[TBL] [Abstract][Full Text] [Related]
3. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-based contrast agents in pediatric magnetic resonance imaging.
Gale EM; Caravan P; Rao AG; McDonald RJ; Winfeld M; Fleck RJ; Gee MS
Pediatr Radiol; 2017 May; 47(5):507-521. PubMed ID: 28409250
[TBL] [Abstract][Full Text] [Related]
5. Contrast-Enhanced Magnetic Resonance Cholangiography: Practical Tips and Clinical Indications for Biliary Disease Management.
Palmucci S; Roccasalva F; Piccoli M; Fuccio Sanzà G; Foti PV; Ragozzino A; Milone P; Ettorre GC
Gastroenterol Res Pract; 2017; 2017():2403012. PubMed ID: 28348578
[TBL] [Abstract][Full Text] [Related]
6. A Manganese Alternative to Gadolinium for MRI Contrast.
Gale EM; Atanasova IP; Blasi F; Ay I; Caravan P
J Am Chem Soc; 2015 Dec; 137(49):15548-57. PubMed ID: 26588204
[TBL] [Abstract][Full Text] [Related]
7. [Radiological diagnosis of primary hepatic malignancy].
Henninger B; Petersen J; Jaschke W
Wien Med Wochenschr; 2013 Mar; 163(5-6):113-22. PubMed ID: 23392810
[TBL] [Abstract][Full Text] [Related]
8. Imaging of liver cancer.
Ariff B; Lloyd CR; Khan S; Shariff M; Thillainayagam AV; Bansi DS; Khan SA; Taylor-Robinson SD; Lim AK
World J Gastroenterol; 2009 Mar; 15(11):1289-300. PubMed ID: 19294758
[TBL] [Abstract][Full Text] [Related]
9. Imaging of liver metastases: MRI.
Namasivayam S; Martin DR; Saini S
Cancer Imaging; 2007; 7(1):2-9. PubMed ID: 17293303
[TBL] [Abstract][Full Text] [Related]
10. Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction.
Lim JS; Kim MJ; Jung YY; Kim KW
Korean J Radiol; 2005; 6(4):229-34. PubMed ID: 16374080
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Reimer P; Schneider G; Schima W
Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
Martí-Bonmatí L; Fog AF; de Beeck BO; Kane P; Fagertun H
Eur Radiol; 2003 Jul; 13(7):1685-92. PubMed ID: 12835986
[TBL] [Abstract][Full Text] [Related]
13. Imaging of metastases to the liver.
Mahfouz AE; Hamm B; Mathieu D
Eur Radiol; 1996; 6(5):607-14. PubMed ID: 8934122
[TBL] [Abstract][Full Text] [Related]
14. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
[TBL] [Abstract][Full Text] [Related]
16. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
[TBL] [Abstract][Full Text] [Related]
17. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
[TBL] [Abstract][Full Text] [Related]
18. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Rofsky NM; Earls JP
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
[TBL] [Abstract][Full Text] [Related]
19. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Mathieu D; Coffin C; Kobeiter H; Caseiro-Alves F; Mahfouz A; Rahmouni A; Diche T
J Magn Reson Imaging; 1999 Aug; 10(2):193-5. PubMed ID: 10441024
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
